title: G3139, a BCL-2 antisense oligo-nucleotide, in AML.
authors.affiliation: Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH
authors.forename: G
authors.initials: G
authors.lastname: Marcucci
authors.forename: W
authors.initials: W
authors.lastname: Stock
authors.forename: G
authors.initials: G
authors.lastname: Dai
authors.forename: M I
authors.initials: MI
authors.lastname: Klisovic
authors.forename: K
authors.initials: K
authors.lastname: Maharry
authors.forename: T
authors.initials: T
authors.lastname: Shen
authors.forename: S
authors.initials: S
authors.lastname: Liu
authors.forename: D A
authors.initials: DA
authors.lastname: Sher
authors.forename: D
authors.initials: D
authors.lastname: Lucas
authors.forename: A
authors.initials: A
authors.lastname: Zwiebel
authors.forename: R A
authors.initials: RA
authors.lastname: Larson
authors.forename: M A
authors.initials: MA
authors.lastname: Caligiuri
authors.forename: C D
authors.initials: CD
authors.lastname: Bloomfield
authors.forename: K K
authors.initials: KK
authors.lastname: Chan
authors.forename: M R
authors.initials: MR
authors.lastname: Grever
authors.forename: J C
authors.initials: JC
authors.lastname: Byrd
mesh_terms: D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D016376:Oligonucleotides, Antisense / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D013873:Thionucleotides / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D013873:Thionucleotides; C408162:oblimersen